PRDM2 and parathyroid gland adenoma: Genome-wide methylation profiling reveals RIZ1 (PRDM2) silencing via promoter hypermethylation in 36% of sporadic parathyroid adenomas, where its loss dysregulates cell cycle by modulating histone methyltransferase activity (66).